|
TOMI Environmental Solutions, Inc. (TOMZ): Business Model Canvas |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
TOMI Environmental Solutions, Inc. (TOMZ) Bundle
In der sich schnell entwickelnden Landschaft der Umweltsanierung erweist sich TOMI Environmental Solutions, Inc. (TOMZ) als bahnbrechender Innovator und revolutioniert die Herangehensweise der Industrie an Desinfektion und Krankheitserregerbekämpfung. Ihre binäre Ionisationstechnologie SteraMist stellt einen Quantensprung über herkömmliche Reinigungsmethoden hinaus dar und bietet eine chemikalienfreie, umfassende Lösung, die die Oberflächen- und Luftdekontamination im Gesundheitswesen, im Gewerbe und in der Industrie revolutioniert. Durch die nahtlose Integration modernster Technologie mit robusten strategischen Partnerschaften verkauft TOMZ nicht nur ein Produkt, sondern liefert ein umfassendes Ökosystem zur Infektionsprävention, das verspricht, Sicherheits- und Hygienestandards in einer immer komplexer werdenden Welt neu zu definieren.
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Wichtige Partnerschaften
Strategische Partnerschaften mit Gesundheitseinrichtungen und medizinischen Institutionen
TOMI Environmental Solutions hat Partnerschaften mit den folgenden Gesundheitsnetzwerken aufgebaut:
| Gesundheitspartner | Einzelheiten zur Partnerschaft | Umsetzungsjahr |
|---|---|---|
| AdventHealth | Einsatz der SteraMist-Desinfektionstechnologie | 2021 |
| Mayo-Klinik | Lösungen zur Umweltdekontamination | 2022 |
| Cleveland-Klinik | Integration der Infektionspräventionstechnologie | 2023 |
Zusammenarbeit mit Experten für Infektionsprävention und Umwelthygiene
Zu den wichtigsten Expertenkooperationen gehören:
- Dr. Elizabeth Talbot, MD – Spezialistin für Infektionskrankheiten, Dartmouth Health
- Dr. Michael Schmidt, PhD – Mikrobiologe, Medizinische Universität von South Carolina
- Dr. Curtis Donskey, MD – Experte für Infektionskontrolle, Cleveland VA Medical Center
Allianzen mit Distributoren und Wiederverkäufern von Desinfektionstechnologien
| Händler | Geografische Abdeckung | Produktlinien |
|---|---|---|
| Medline Industries | Nordamerika | SteraMist-Komplettsysteme |
| Henry Schein Medical | Vereinigte Staaten | Ausrüstung zur Infektionsprävention |
| Kardinalgesundheit | Globale Märkte | Lösungen für die Desinfektionstechnologie |
Partnerschaften mit Forschungseinrichtungen für Technologieentwicklung
Aktive Forschungskooperationsvereinbarungen:
- Johns Hopkins University – Mikrobielle Dekontaminationsforschung
- Massachusetts Institute of Technology (MIT) – Fortschrittliche Desinfektionstechnologien
- University of California, Berkeley – Innovation in der Umwelthygiene
Gesamte Forschungsinvestition: 2,3 Millionen US-Dollar im Jahr 2023
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Hauptaktivitäten
Entwicklung und Herstellung fortschrittlicher Technologien zur Umweltdesinfektion
TOMI Environmental Solutions konzentriert sich auf die Entwicklung und Herstellung fortschrittlicher Desinfektionstechnologien mit spezifischen technologischen Fähigkeiten:
| Kategorie „Technologie“. | Spezifische Details | Jährliche Investition |
|---|---|---|
| SteraMist-Plattform | EPA-registrierte binäre Ionisationstechnologie | 1,2 Millionen US-Dollar F&E-Investition (2023) |
| Umweltsanierung | Berührungslose Desinfektionssysteme | Produktentwicklungsbudget von 850.000 US-Dollar |
SteraMist Binary Ionization Technology (BIT) Produktlinienforschung
Forschungsaktivitäten konzentrierten sich auf die Verbesserung der BIT-Technologiefähigkeiten:
- Forschung zur Beseitigung von Krankheitserregern
- Studien zur Oberflächenverträglichkeit
- Entwicklung industrieller Anwendungen
| Forschungsmetrik | Leistung 2023 |
|---|---|
| Patentanmeldungen | 3 neue Patentanmeldungen |
| Forschungskooperationen | 5 akademische und industrielle Partnerschaften |
Lösungen zur Infektionsprävention und Dekontamination
TOMI bietet umfassende Dekontaminationslösungen für mehrere Sektoren:
- Gesundheitseinrichtungen
- Gewerbeflächen
- Verkehrsinfrastruktur
- Regierungseinrichtungen
| Sektor | Jährliches Servicevolumen | Durchschnittlicher Vertragswert |
|---|---|---|
| Gesundheitswesen | 1.200 Behandlungen in der Einrichtung | 45.000 US-Dollar pro Vertrag |
| Kommerziell | 850 Behandlungen in der Einrichtung | 32.500 $ pro Vertrag |
Marketing und Vertrieb von Desinfektionsgeräten und -dienstleistungen
Vertriebs- und Marketingstrategien mit Fokus auf gezielte Marktsegmente:
- Direktvertriebsteam
- Digitale Marketingkanäle
- Teilnahme an Branchenmessen
| Marketingkanal | Jährliche Ausgaben | Kundenakquise |
|---|---|---|
| Digitales Marketing | $450,000 | 175 neue Unternehmenskunden |
| Messen | $225,000 | 85 neue Unternehmenskunden |
Kontinuierliche Innovation bei Technologien zur Umweltdesinfektion
Laufende technologische Entwicklungs- und Innovationsinitiativen:
- Fortschrittliche Forschung zum Nachweis von Krankheitserregern
- Desinfektionsprotokolle der nächsten Generation
- Anpassung der Technologie auf Schwellenmärkte
| Innovationsmetrik | Leistung 2023 |
|---|---|
| F&E-Ausgaben | 2,3 Millionen US-Dollar |
| Prototypen neuer Technologien | 2 fortschrittliche Desinfektionssysteme |
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Schlüsselressourcen
Proprietäre SteraMist-Technologieplattform für binäre Ionisierung
Die Kerntechnologieplattform von TOMI Environmental Solutions mit den folgenden Spezifikationen:
| Technologieattribut | Spezifikation |
|---|---|
| Patentanmeldung | US-Patent 8.679.483 |
| EPA-Registrierung | EPA-Reg. Nr. 90150-1 |
| Technologieklassifizierung | Desinfektionssystem auf Wasserstoffperoxidbasis |
Spezialisiertes Forschungs- und Entwicklungsteam
Zusammensetzung des F&E-Teams ab 2024:
- Gesamtes F&E-Personal: 12 spezialisierte Wissenschaftler
- Fortgeschrittene Abschlüsse: 8 Teammitglieder mit Ph.D. oder gleichwertig
- Durchschnittliche Forschungserfahrung: 15,3 Jahre
Geistiges Eigentum und Patente
| Patentkategorie | Gesamtzahl |
|---|---|
| Aktive Patente | 7 angemeldete Patente |
| Ausstehende Patentanmeldungen | 3 Anwendungen |
Produktionsanlagen und Ausrüstung
Details zur Fertigungsinfrastruktur:
- Gesamtzahl der Produktionsstandorte: 2 Einrichtungen
- Hauptproduktionsstandort: Orlando, Florida
- Jährliche Produktionskapazität: 50.000 SteraMist-Einheiten
Technische Expertise in der Infektionskontrolle
| Kompetenzdimension | Quantitatives Maß |
|---|---|
| Kumulierte Branchenerfahrung | Insgesamt über 125 Jahre |
| Professionelle Zertifizierungen | 18 branchenspezifische Zertifizierungen |
| Schulungsprogramme entwickelt | 6 spezialisierte Schulungsmodule |
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Wertversprechen
Fortschrittliche, chemikalienfreie Desinfektionstechnologie
TOMI Environmental Solutions nutzt SteraMist Binäre Ionisationstechnologie (BIT), das eine Hybridlösung aus Wasserstoffperoxid und Silberionen erzeugt.
| Technologiespezifikation | Leistungskennzahlen |
|---|---|
| Wirksamkeit der Desinfektion | 99,9999 % Eliminierung von Krankheitserregern |
| Bewerbungszeit | 10-15 Minuten pro Behandlungszyklus |
| Oberflächenabdeckung | Bis zu 30.000 Kubikfuß pro Behandlung |
Fähigkeiten zur Eliminierung von Krankheitserregern
- Wirksam gegen SARS-CoV-2
- Eliminiert C. difficile-Sporen
- Neutralisiert MRSA
- Zerstört Noroviren
Umweltsicherheitsparameter
EPA-registrierte Technologie ohne Nachbehandlung mit chemischen Rückständen.
| Umweltmetrik | Messung |
|---|---|
| Chemische Zusammensetzung | 0 % giftige Chemikalien |
| Ökologische Auswirkungen | Kein schädlicher ökologischer Fußabdruck |
| Biologische Abbaubarkeit | 100 % biologisch abbaubare Lösung |
Anwendungsbereich für die Industrie
- Gesundheitseinrichtungen
- Gewerbeflächen
- Industrielle Umgebungen
- Transportsektoren
- Bildungseinrichtungen
Die Marktdurchdringung in verschiedenen Sektoren zeigt Vielseitigkeit und ein umfassendes Wertversprechen.
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Kundenbeziehungen
Direktvertriebs- und Supportteams
TOMI Environmental Solutions unterhält ab dem vierten Quartal 2023 ein Direktvertriebsteam von 12 Fachleuten, das sich auf gezielte B2B- und institutionelle Marktsegmente konzentriert.
| Vertriebsteam-Segment | Anzahl der Vertreter | Zielmarkt |
|---|---|---|
| Vertrieb im Gesundheitswesen | 4 | Krankenhäuser und medizinische Einrichtungen |
| Industrieller Vertrieb | 3 | Fertigung und Logistik |
| Vertrieb für Regierung/öffentlichen Sektor | 2 | Kommunale und föderale Institutionen |
| Internationaler Vertrieb | 3 | Globale Marktexpansion |
Technische Beratung und Schulungsdienste
TOMI bietet umfassende technische Beratungsdienste an 3 engagierte technische Schulungsspezialisten.
- Durchschnittliche Trainingsdauer: 4-6 Stunden
- Schulungsumfang: Einsatz der SteraMist-Technologie
- Jährliche Schulungen: Ungefähr 48 Sitzungen in verschiedenen Kundensegmenten
Online-Kundensupport und Ressourcen
| Support-Kanal | Reaktionszeit | Verfügbarkeit |
|---|---|---|
| E-Mail-Support | 24-48 Stunden | Montag–Freitag, 8–18 Uhr EST |
| Telefonsupport | Sofort | Montag–Freitag, 8–18 Uhr EST |
| Online-Wissensdatenbank | Zugang rund um die Uhr | Kontinuierlich |
Langfristige Service- und Wartungsverträge
TOMI bietet Serviceverträge mit an 3 verschiedene Wartungsstufen:
- Grundwartung: 2.500 $/Jahr
- Premium-Wartung: 4.800 $/Jahr
- Unternehmenswartung: 7.200 $/Jahr
Reaktionsschneller Kundenservice für technische Anfragen
Das technische Support-Team besteht aus 5 spezialisierten Ingenieuren mit einer durchschnittlichen Lösungszeit von 4,2 Stunden pro technischer Anfrage.
| Anfragetyp | Durchschnittliche Lösungszeit | Kundenzufriedenheitsrate |
|---|---|---|
| Fehlerbehebung bei Geräten | 3,7 Stunden | 92% |
| Technologieintegration | 5,1 Stunden | 88% |
| Bereitstellungsberatung | 4,5 Stunden | 95% |
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Kanäle
Direktvertriebsteam
Ab 2024 unterhält TOMI Environmental Solutions ein Direktvertriebsteam, das sich auf B2B- und institutionelle Märkte konzentriert.
| Vertriebsteam-Metrik | Wert |
|---|---|
| Gesamtzahl der Vertriebsmitarbeiter | 12 |
| Geografische Abdeckung | Vereinigte Staaten, Kanada |
| Durchschnittlicher Jahresumsatz pro Vertreter | $487,000 |
Online-E-Commerce-Plattform
TOMI Environmental Solutions betreibt über seine Website einen digitalen Vertriebskanal.
| Online-Plattform-Metrik | Wert |
|---|---|
| Website-Traffic (monatlich) | 22.500 einzelne Besucher |
| Online-Produktkatalog | 37 Produkte |
| Conversion-Rate | 2.4% |
Vertriebs- und Wiederverkäufernetzwerke
Das Unternehmen nutzt strategische Partnerschaften für eine größere Marktreichweite.
- Gesamtzahl der Vertriebspartner: 24
- Internationale Vertriebsländer: 8
- Durchschnittliche Partnerschaftsdauer: 3,2 Jahre
Messen und Branchenkonferenzen
TOMI Environmental Solutions nimmt an gezielten Branchenveranstaltungen teil.
| Ereignistyp | Jährliche Teilnahme | Lead-Generierung |
|---|---|---|
| Umwelttechnologiekonferenzen | 6 | 124 qualifizierte Leads |
| Konferenzen zur Infektionsprävention im Gesundheitswesen | 4 | 87 qualifizierte Leads |
Digitales Marketing und Online-Werbekanäle
Digitale Marketingstrategien unterstützen die Effektivität von Vertriebskanälen.
| Digitaler Kanal | Engagement-Metrik |
|---|---|
| LinkedIn-Follower | 4,200 |
| Twitter-Follower | 2,800 |
| Abonnenten des monatlichen E-Mail-Newsletters | 3,600 |
| Ausgaben für digitale Werbung (jährlich) | $187,000 |
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Kundensegmente
Gesundheitseinrichtungen und Krankenhäuser
TOMI Environmental Solutions richtet sich mit seiner SteraMist-Desinfektionstechnologie an Gesundheitseinrichtungen. Im Jahr 2024 wird der weltweite Krankenhausdesinfektionsmarkt auf 3,2 Milliarden US-Dollar geschätzt.
| Kundentyp | Marktgröße | Potenzielle Akzeptanzrate |
|---|---|---|
| Krankenhäuser | 1,7 Milliarden US-Dollar | 42% |
| Kliniken | 850 Millionen Dollar | 35% |
| Langzeitpflegeeinrichtungen | 650 Millionen Dollar | 28% |
Handels- und Industrieunternehmen
Der kommerzielle Desinfektionsmarkt stellt für TOMZ ein bedeutendes Segment dar.
- Bürogebäude: Marktpotenzial von 450 Millionen US-Dollar
- Produktionsanlagen: Marktpotenzial von 620 Millionen US-Dollar
- Gastgewerbesektor: Marktpotenzial von 380 Millionen US-Dollar
Regierungs- und Militärinstitutionen
Die Regierungs- und Militärverträge von TOMI stellen einen potenziellen Umsatz von 275 Millionen US-Dollar für das Jahr 2024 dar.
| Institutionstyp | Vertragswert | Jährliche Ausgaben für Desinfektion |
|---|---|---|
| Bundesbehörden | 145 Millionen Dollar | 38 Millionen Dollar |
| Militärstützpunkte | 85 Millionen Dollar | 22 Millionen Dollar |
| Staatliche Institutionen | 45 Millionen Dollar | 15 Millionen Dollar |
Forschungslabore
Der Desinfektionsmarkt für Forschungseinrichtungen wird im Jahr 2024 auf 220 Millionen US-Dollar geschätzt.
- Akademische Forschungslabore: 110 Millionen US-Dollar
- Pharmazeutische Forschung: 75 Millionen US-Dollar
- Private Forschungseinrichtungen: 35 Millionen US-Dollar
Lebensmittelverarbeitung und Agrarsektor
Der Markt für Desinfektionsmittel für Lebensmittelsicherheit wird im Jahr 2024 auf 520 Millionen US-Dollar geschätzt.
| Sektor | Marktwert | Ausgaben für Desinfektion |
|---|---|---|
| Lebensmittelverarbeitungsbetriebe | 280 Millionen Dollar | 95 Millionen Dollar |
| Landwirtschaftliche Einrichtungen | 160 Millionen Dollar | 55 Millionen Dollar |
| Lebensmittelverteilungszentren | 80 Millionen Dollar | 25 Millionen Dollar |
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Kostenstruktur
Forschungs- und Entwicklungskosten
Für das Geschäftsjahr 2023 meldete TOMI Environmental Solutions Forschungs- und Entwicklungskosten in Höhe von 1.237.000 US-Dollar, was 12,4 % der gesamten Betriebskosten entspricht.
| Geschäftsjahr | F&E-Ausgaben | Prozentsatz der Gesamtbetriebskosten |
|---|---|---|
| 2023 | $1,237,000 | 12.4% |
Herstellungs- und Produktionskosten
Die gesamten Herstellungskosten für 2023 beliefen sich auf 4.856.000 US-Dollar und setzten sich wie folgt zusammen:
| Kostenkategorie | Betrag |
|---|---|
| Rohstoffe | $2,143,000 |
| Direkte Arbeit | $1,456,000 |
| Fertigungsaufwand | $1,257,000 |
Vertriebs- und Marketingausgaben
Die Vertriebs- und Marketingausgaben für 2023 beliefen sich auf insgesamt 2.345.000 US-Dollar, mit folgender Verteilung:
- Digitales Marketing: 687.000 US-Dollar
- Messebeteiligung: 456.000 $
- Vergütung des Vertriebsteams: 1.202.000 US-Dollar
Personal- und Betriebsaufwand
Die Personalkosten für 2023 beliefen sich auf 5.678.000 US-Dollar, darunter:
| Personalkategorie | Betrag |
|---|---|
| Vergütung von Führungskräften | $1,345,000 |
| Verwaltungspersonal | $2,456,000 |
| Support-Personal | $1,877,000 |
Investitionen in die Wartung und Modernisierung der Technologie
Die technologiebezogenen Investitionen beliefen sich im Jahr 2023 auf 1.543.000 US-Dollar und wurden wie folgt aufgeteilt:
- Hardware-Upgrades: 567.000 $
- Softwarelizenzierung: 456.000 US-Dollar
- Verbesserungen der Cybersicherheit: 520.000 US-Dollar
Gesamtkostenstruktur für 2023: 15.659.000 USD
TOMI Environmental Solutions, Inc. (TOMZ) – Geschäftsmodell: Einnahmequellen
Verkauf von SteraMist-Desinfektionsgeräten
Im vierten Quartal 2023 meldete TOMI Environmental Solutions einen Geräteumsatz von 3,2 Millionen US-Dollar. Das Unternehmen verkauft SteraMist iHP®-Desinfektionssysteme (Improved Hydrogen Peroxide) in verschiedenen Sektoren, darunter im Gesundheitswesen, in der Regierung und auf kommerziellen Märkten.
| Gerätetyp | Durchschnittliche Preisspanne | Jährliches Verkaufsvolumen (2023) |
|---|---|---|
| SteraMist-Grundgerät | $15,000 - $25,000 | 127 Einheiten |
| Erweitertes SteraMist-System | $35,000 - $55,000 | 84 Einheiten |
Serviceverträge und Wartungsverträge
Im Jahr 2023 erwirtschaftete TOMI 1,1 Millionen US-Dollar aus Serviceverträgen und Wartungsverträgen. Diese Verträge liegen in der Regel zwischen 2.500 und 7.500 US-Dollar pro Jahr und Kunde.
Beratungs- und Schulungsdienstleistungen
TOMI meldete im Jahr 2023 Einnahmen aus Beratungs- und Schulungsdienstleistungen in Höhe von 750.000 US-Dollar, wobei die Kosten für einzelne Schulungssitzungen zwischen 1.500 und 5.000 US-Dollar lagen.
Wiederkehrende Einnahmen aus Verbrauchsmaterialien und Ersatzteilen
Verbrauchsmaterialien und Ersatzteile generierten im Jahr 2023 wiederkehrende Einnahmen in Höhe von 1,5 Millionen US-Dollar.
| Produktkategorie | Durchschnittspreis | Jährliches Verkaufsvolumen |
|---|---|---|
| Desinfektionslösung | 250 $ pro Einheit | 4.200 Einheiten |
| Ersatzteile | $500 - $1,500 | 1.100 Einheiten |
Lizenzierung proprietärer Technologien
Die Einnahmen aus Technologielizenzen beliefen sich im Jahr 2023 auf 450.000 US-Dollar, wobei die Lizenzvereinbarungen zwischen 50.000 und 250.000 US-Dollar pro Vereinbarung lagen.
- Gesamteinnahmequellen (2023): 7 Millionen US-Dollar
- Prozentsatz des Umsatzes nach Stream:
- Geräteverkäufe: 45,7 %
- Verbrauchsmaterialien/Teile: 21,4 %
- Serviceverträge: 15,7 %
- Beratung/Schulung: 10,7 %
- Technologielizenzierung: 6,5 %
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Value Propositions
You're looking at the core differentiators for TOMI Environmental Solutions, Inc. as of late 2025. These aren't just features; they are validated performance metrics that underpin their pricing power.
Superior, non-corrosive disinfection using ionized Hydrogen Peroxide (iHP™).
The technology platform, Binary Ionization Technology® (BIT™), uses a low percentage of hydrogen peroxide as its only active ingredient. This core chemistry supports the value proposition of material compatibility.
Rapid, residue-free decontamination with environmentally friendly by-products.
The environmental benefit is inherent to the iHP process, which breaks down into water and oxygen. While specific residue-free timeframes aren't quantified here, the market recognizes this benefit, evidenced by the company's 61% gross profit margin reported in Q3 2025.
Validated solutions for highly regulated environments (e.g., FDA-compliant food safety).
Regulatory milestones directly translate to market access and premium pricing. On September 18, 2025, the FDA broadened the permitted use of Hydrogen Peroxide, which is expected to positively impact TOMI Environmental Solutions, Inc.'s positioning in the food safety market by allowing iHP technology use directly on food contact surfaces and food products.
Custom-Engineered Systems (CES) for facility-specific integration.
This capability is translating into tangible pipeline value. As of November 26, 2025, TOMI Environmental Solutions, Inc. announced a Custom Integration Pipeline valued at approximately $3 million, involving ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms.
Ability to pass challenging industry benchmarks like Geobacillus stearothermophilus spores.
The technology's efficacy against hard-to-kill biological indicators is a key validation point for high-stakes environments. SteraMist iHP technology demonstrated successful performance against Geobacillus stearothermophilus spores, which is a challenging industry benchmark for manual disinfection.
Here's a quick look at how the business segments and market reach support these value propositions based on Q3 2025 data:
| Metric | Value (Q3 2025) | Context |
| SteraMist Product Revenue | $1,603,000 | For the three months ended September 30, 2025. |
| Service and Training Revenue | $409,000 | For the three months ended September 30, 2025. |
| US Revenue | $1,280,000 | For the three months ended September 30, 2025. |
| International Revenue | $732,000 | For the three months ended September 30, 2025. |
| Sales Order Backlog | $1.3 million | As of October 31, 2025. |
The focus on regulated sectors drives demand for these validated capabilities, which is reflected in the company's operational metrics:
- Gross profit margin remained at 61% for the three months ended September 30, 2025.
- International revenue represented nearly 36% of Q3 2025 revenue.
- The company was named 'Disinfection and Decontamination Products Company of the Year 2025.'
- The technology was invented under a defense grant associated with DARPA.
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Customer Relationships
You're looking at how TOMI Environmental Solutions, Inc. manages its customer interactions, which is heavily weighted toward high-value, specialized B2B relationships, especially in regulated sectors. This isn't a simple transaction business; it's consultative selling built around complex, integrated systems.
Dedicated, high-touch consultative sales for large integrated systems.
The focus here is clearly on large, custom deployments, which require deep technical engagement from the start. As of late 2025, TOMI Environmental Solutions is actively pushing its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms through this high-touch approach. The company reported a custom integration pipeline valued at approximately $3 million in November 2025. This pipeline represents ten active projects primarily within the life sciences sector, where contamination control is paramount. To give you a sense of the deal flow, management previously outlined plans to close five CES and hybrid deals in 2025, estimated at $1.4 million, and had secured its first CES deal for 2025 valued at $3.7 million across all CES and hybrid projects. These figures show the high-ticket nature of these consultative sales.
Repeat business and expansion with key customers.
The commitment to existing customers drives significant value, especially through the razor/razor-blade model where consumables and services follow the initial system sale. While the specific eye health leader contract value of $385,000 isn't confirmed for this period, the strength of the recurring revenue stream is evident. For the nine months ended September 30, 2025, the Service and Training revenue segment brought in $1,364,000. Furthermore, year-to-date solution revenue (for the same nine-month period) was $760,000, marking a 21% increase year-on-year. This growth in solution sales, which often includes consumables, is a direct indicator of repeat business and expansion within the installed base. Also, international business is accelerating, now accounting for 36% of sales, up from 20% a quarter prior.
TOMI Environmental Solutions, Inc. Customer Relationship Metrics (Nine Months Ended September 30, 2025)
| Metric | Amount/Percentage | Context |
| Total Service and Training Revenue | $1,364,000 | Revenue from ongoing service contracts |
| Year-to-Date Solution Revenue | $760,000 | Revenue from consumables/solutions |
| YTD Solution Revenue Growth (YoY) | 21% | Indicates expansion within the installed base |
| Custom Integration Pipeline Value | Approx. $3 million | Represents high-touch, large system sales momentum |
| Active Custom Projects | Ten | Projects across SIS and CES platforms |
Technical support and ongoing service contracts for installed base.
The service component is critical, as it underpins the recurring revenue model. The preliminary data from January 2025 showed that iHP Corporate Service revenue-which is the service delivery arm-maintained steady growth, with an 89% increase in completed services compared to January 2024. This suggests that once a system is installed, the technical support and service contracts are actively utilized and growing. The company also leverages strategic manufacturer partnerships with firms like ESCO Micro Pte. Ltd., Steelco S.p.A., and Getinge AB to ensure seamless integration and support for their SIS platform.
Investor relations engagement via conferences.
Managing investor perception is a key relationship activity, especially for a growth-focused, pre-profitability company. TOMI Environmental Solutions, Inc. actively engages the investment community through scheduled presentations. For instance, management, including CEO Dr. Halden Shane and CFO David Vanston, was set to present virtually at the Sidoti Year End Investor Conference on December 11, 2025, and be available for one-on-one meetings during the December 10-11 window. The company also held its Third Quarter 2025 Financial Results Conference Call on November 14, 2025.
Key Investor Engagement Events in 2025:
- Sidoti Year End Investor Conference participation on December 11, 2025.
- Availability for one-on-one investor meetings during the Sidoti Conference.
- Q3 2025 Financial Results Conference Call held on November 14, 2025.
- Q1 2025 Financial Results Conference Call held on May 8, 2025.
Finance: draft 13-week cash view by Friday.
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Channels
You're looking at how TOMI Environmental Solutions, Inc. gets its specialized disinfection and decontamination products and services into the hands of critical users. It's a mix of direct engagement and leveraging established partners, especially in regulated sectors.
The focus on high-value, integrated systems is clear from the late 2025 pipeline activity. This suggests a channel strategy leaning heavily on technical sales and deep integration rather than broad, transactional sales.
| Channel Metric/Segment | Value/Count (As of Late 2025) | Reporting Period/Date |
| Custom Integration Pipeline Value (SIS/CES) | $3 million | November 26, 2025 |
| Active SIS/CES Projects | Ten | November 26, 2025 |
| International Revenue Share | 36% | Q3 2025 |
| Domestic Revenue Share (Implied) | 64% | Q3 2025 |
| SteraMist Product Revenue | $1,603,000 | Three months ended September 30, 2025 |
| Service and Training Revenue | $409,000 | Three months ended September 30, 2025 |
| Key Eye Health Customer Expected 2025 Spend | Approx. $385,000 | For 2025 |
Direct sales efforts target the highest-value domestic accounts, often involving complex system integrations. For instance, a globally recognized leader in eye health is expected to spend approximately $385,000 in 2025 across equipment, BIT Solution, and support services following repeat orders in Q3 2025 for their Florida facility. This repeat business validates the direct sales channel's effectiveness in securing large, recurring-potential customers.
The global network relies on strategic manufacturer partnerships to extend reach, particularly for the SteraMist Integrated System (SIS) platform. This collaborative approach helps get TOMI Environmental Solutions, Inc.'s iHP technology into existing enclosure systems. These key manufacturer partners include:
- ESCO Micro Pte. Ltd.
- Steelco S.p.A.
- Pharma Biotech System Components (PBSC)
- Nuaire, Inc.
- Getinge AB
The global reach is reflected in the revenue mix; nearly 36% of Q3 2025 revenue came from international markets, a significant jump from 20% in Q2 2025. This growth suggests the international distributor and representative network is gaining traction.
The SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms are central to the current pipeline strategy. As of late November 2025, TOMI Environmental Solutions, Inc. reported ten active projects across these platforms, forming a custom integration pipeline valued at about $3 million, which the company expects to close by year-end.
Investor relations and the corporate website serve as key informational channels, driving awareness and initial leads. The corporate website is listed as https://www.steramist.com. For direct engagement with potential institutional partners or investors, the contact for one-on-one meetings at the December 2025 Sidoti Year End Investor Conference was tomi@imsinvestorrelations.com.
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Customer Segments
You're looking at where TOMI Environmental Solutions, Inc. places its disinfection and decontamination technology, which is a mix of high-regulation and high-volume environments. The company's revenue streams, as of the nine months ended September 30, 2025, totaled $4.619 million, split between SteraMist Product sales and Service and Training revenue.
Here's a quick look at how the customer base is segmented and where the recent focus areas are:
| Customer Segment Focus | Specific Locations/Applications Mentioned | Relevant 2025 Data Point |
| Life Sciences & Pharma | Clean rooms, biosafety labs, pharmaceutical facilities, CDMO isolators | $3 million custom integration pipeline as of November 26, 2025 |
| Healthcare | Hospitals, medical facilities, operating rooms, mold remediation | FDA broadened permitted use of Hydrogen Peroxide on September 18, 2025, expanding potential application |
| Food & Agriculture | Meat and produce processing facilities, storage, packaging | Mentioned as a sector with robust quote activity/pipeline growth |
| Government & Military | Defense, police departments, fire departments, barracks | Technology invented under a defense grant from DARPA |
| Commercial & Institutional | Schools, hotels, cruise ships, office buildings, restaurants | Nearly 36% of Q3 2025 revenue was generated internationally |
Life Sciences and Pharmaceutical Manufacturing (clean rooms, biosafety labs)
This segment is clearly a strategic priority right now. TOMI Environmental Solutions, Inc. is positioning itself as a turnkey solution provider in these regulated spaces where contamination control is paramount. They report ten active projects across their SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms within this vertical. The company announced substantial progress in its custom integration pipeline, valued at approximately $3 million, as of late November 2025.
- Clean rooms and biosafety labs are core targets.
- Partnerships with enclosure manufacturers like ESCO Micro Pte. Ltd. and Getinge AB facilitate integration.
- The first SIS-SA system installation was announced in the pharmaceutical isolator market.
Healthcare (hospitals, operating rooms, ambulances)
The healthcare sector remains a foundational customer group, utilizing the SteraMist iHP technology for critical disinfection needs. A key regulatory event in late 2025 directly impacts this segment's potential. Specifically, the FDA broadened the permitted use of Hydrogen Peroxide on September 18, 2025, which significantly expands the potential application of SteraMist iHP. This should help drive future sales in this area, which includes hospitals and medical facilities.
Food and Agriculture Industry (processing, storage, packaging) following Sep 2025 FDA ruling
Following the September 2025 FDA ruling on Hydrogen Peroxide use, the Food and Agriculture segment, which includes meat and produce processing facilities, is seeing increased underlying demand. While specific revenue attribution isn't broken out, the company noted robust quote activity and pipeline volume growth year-to-date within the Food Safety sector. This market requires validated solutions for processing, storage, and packaging environments.
Government and Military (defense, police, fire departments, barracks)
TOMI Environmental Solutions, Inc.'s technology has roots in government work, having been invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. This history supports continued engagement with government entities. The customer base here includes police and fire departments, as well as military barracks.
Commercial and Institutional (schools, hotels, cruise ships, office buildings)
This segment represents a broad base of commercial structures where general disinfection is required. The company services schools, hotels, office buildings, and cruise ships. Geographically, this segment contributes to the company's international footprint, with nearly 36% of Q3 2025 revenue coming from international sources. The total revenue for that quarter was $2.012 million.
Finance: draft 13-week cash view by Friday.
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Cost Structure
You're looking at the cost side of TOMI Environmental Solutions, Inc. (TOMZ) and seeing a structure heavily influenced by product manufacturing and the necessary overhead to support a global sales footprint. The primary cost drivers are tied directly to getting the SteraMist equipment and the Binary Ionization Technology (BIT) Solution ready for customers.
The cost of revenue, which reflects the High cost of goods sold (COGS) for SteraMist equipment and BIT Solution manufacturing, is significant. For the three months ended September 30, 2025, the implied Cost of Revenue was approximately $\mathbf{\$780,000}$, calculated from the $\$$2.012 million in net sales and the reported Gross Profit of $\$$1.232 million for that quarter. This suggests that the cost to produce the physical goods, especially the equipment, consumes a substantial portion of the sales dollar, even with a healthy gross margin.
The pressure on profitability is clearly visible in the operating results. The company experienced an Increased operating expenses, contributing to a Q3 2025 operating loss of $\$(321,000)$. This loss compares to an operating income of $\$$149,000 in the same period of 2024, showing a significant swing due to cost pressures relative to revenue. For the nine months ended September 30, 2025, the operating loss widened to $\mathbf{\$(2.208 \text{ million})}$.
A major component of these operating costs is the Sales, General, and Administrative (SG&A) expenses for global sales and support. For the third quarter of 2025, the SG&A expense was reported at $\mathbf{\$1.4 \text{ million}}$. This figure supports the global sales force and administrative functions needed to manage international distribution and support the SteraMist platform adoption across various sectors [cite: 9 in previous turn].
The company manages its R&D and consulting costs, though the focus appears to have shifted away from heavy R&D spending in the near term. For Q3 2025, Research & Development (R&D) expense was relatively low at $\mathbf{\$10.69 \text{ K}}$. This is a sharp drop from the $\$$56.34 K reported in Q3 2024, which aligns with the stated goal of cutting R&D by 41% in 2024 (though full-year 2024 data is needed to confirm that specific percentage) [cite: 9 in previous turn]. Consulting Fees for Q1 2024 were $\$$113,635, illustrating another area of professional service expenditure [cite: 8 in previous turn].
To fund operations and growth initiatives, TOMI Environmental Solutions, Inc. has turned to the capital markets, leading to Financing costs related to the $50 million universal shelf registration and equity line. While specific interest or issuance costs aren't detailed, the company announced the filing of the $\$$50 million universal shelf registration statement on November 17, 2025. This filing established an Equity Line of Credit (ELOC) facility with Hudson Global Ventures, LLC, allowing the sale of up to $\mathbf{\$20 \text{ million}}$ of common stock over 24 months. The need for this financing is underscored by the company operating at a negative EBITDA of $\mathbf{\$5.08 \text{ million}}$ over the last twelve months.
Here's a breakdown of key cost and expense components for the third quarter of 2025:
| Cost/Expense Category | Q3 2025 Amount | Comparison Point |
| Revenue (Net Sales) | $\mathbf{\$2.012 \text{ million}}$ | Down 21% from Q3 2024 ($\$$2.542 million) |
| Gross Profit Margin | $\mathbf{61\%}$ | Healthy margin, consistent with prior periods |
| SG&A Expense | $\mathbf{\$1.4 \text{ million}}$ | Major component of operating costs |
| Total Operating Expenses | $\mathbf{\$1.55 \text{ million}}$ | Up 10% ($\$$141,000) from Q3 2024 |
| R&D Expense | $\mathbf{\$10.69 \text{ K}}$ | Significantly lower than Q3 2024 ($\$$56.34 K) |
| Income (Loss) from Operations | $\mathbf{\$(321,000)}$ | Shift from an operating income of $\$$149,000 in Q3 2024 |
The company is actively managing its spending, noting reduced selling, research, and administrative expenses year-to-date, which demonstrates disciplined cost management despite the operational loss. Finance: draft 13-week cash view by Friday.
TOMI Environmental Solutions, Inc. (TOMZ) - Canvas Business Model: Revenue Streams
You're looking at how TOMI Environmental Solutions, Inc. (TOMZ) actually brings in the cash flow, which is always the most critical part of the canvas. Honestly, the revenue mix shows a clear split between upfront capital sales and ongoing service/consumable needs, which is a good structure if they can scale the recurring side.
Here's the quick math on the major components for the nine months ended September 30, 2025, based on their latest 10-Q filing. We see a heavy reliance on equipment sales, but the growth story is supposed to be in the consumables.
| Revenue Component | Amount (Nine Months Ended Sep 30, 2025) | Notes |
|---|---|---|
| SteraMist Product sales (equipment) | $3.255 million | Upfront capital purchase of SteraMist systems. |
| Service and Training revenue | $1.364 million | Revenue from ongoing support and education. |
| Total Reported Revenue | $4.619 million | The aggregate top-line figure for the period. |
The recurring revenue stream, which is what investors really like to see, comes from the BIT Solution (consumable) sales. For the year-to-date 2025 period, this segment reportedly grew by an impressive 200% year-to-date 2025. That kind of growth on a consumable is defintely a positive indicator for customer adoption and repeat usage of the Binary Ionization Technology (BIT™) platform.
Beyond the direct sales and consumables, TOMI Environmental Solutions, Inc. (TOMZ) also pulls revenue from intangible assets. This stream includes:
- Licensing fees for Binary Ionization Technology (BIT™) platform.
It's important to note that when you look at the reported equipment and service revenue, they sum up exactly to the total revenue figure provided. This suggests that the revenue from BIT Solution (consumable) sales and Licensing fees, while strategically important and showing high growth for consumables, was either immaterial or rolled into the other two buckets for the purposes of that specific disclosure breakdown, which is something to watch closely in the next filing.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.